EU strikes balance with new Bolar provision
Europe is following the US example and introducing a Bolar provision to exempt generic research aimed at obtaining regulatory approval. Marjan Noor and Camilla Smith examine the proposal and how it is likely to be implemented by member states
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
